tiprankstipranks
Xortx Therapeutics (XRTX)
:XRTX
US Market
Holding XRTX?
Track your performance easily

Xortx Therapeutics (XRTX) Financial Statements

52 Followers

Xortx Therapeutics Financial Overview

Xortx Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.035; its P/E ratio is ―; Xortx Therapeutics is scheduled to report earnings on April 30, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -587.01K$ 170.07K$ -3.02M$ 2.70M$ -1.33M
EBITDA$ -561.06K$ 203.12K$ -2.99M$ 2.72M$ -1.32M
Net Income Common Stockholders$ -587.01K$ 170.07K$ -3.02M$ 2.70M$ -1.33M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.30M$ 3.08M$ 3.84M$ 3.45M$ 5.07M
Total Assets$ 3.85M$ 4.80M$ 6.05M$ 5.47M$ 6.64M
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 1.72M$ 2.09M$ 3.56M$ 825.94K$ 553.76K
Stockholders Equity$ 2.13M$ 2.70M$ 2.49M$ 4.64M$ 6.09M
Cash Flow-
Free Cash Flow-$ -745.62K$ -1.31M$ -1.31M$ -1.08M
Operating Cash Flow-$ -736.54K$ -1.30M$ -1.30M$ -1.07M
Investing Cash Flow-$ -9.08K$ -2.62K$ -9.79K$ -7.30K
Financing Cash Flow-$ -8.86K$ 1.70M$ -312.25K$ -16.67K
Currency in USD

Xortx Therapeutics Earnings and Revenue History

Xortx Therapeutics Debt to Assets

Xortx Therapeutics Cash Flow

Xortx Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis